QCM
RCUS icon

Quantinno Capital Management’s Arcus Biosciences RCUS Stock Holding History

Quantinno Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
17,295
+1,349
+8% +$29.1K ﹤0.01% 2913
2025
Q4 		$380K Buy
15,946
+735
+5% +$15K ﹤0.01% 2668
2025
Q3 		$207K Buy
+15,211
New +$158K ﹤0.01% 2744

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Quantinno Capital Management's RCUS Position: Q1 2026 in Review

Quantinno Capital Management increased its Arcus Biosciences (RCUS) stake by 8.5% in Q1 2026, buying an estimated $29.1K and bringing the position to 17,295 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2913.

Quantinno Capital Management first reported a position in RCUS in Q3 2025 and has held it in 3 quarters since. The position peaked at $380K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Quantinno Capital Management held 17,295 shares of Arcus Biosciences worth $374K as of Q1 2026.
  • Quantinno Capital Management bought 1,349 Arcus Biosciences shares in Q1 2026, an estimated $29.1K.
  • Arcus Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2913 holding.
  • Quantinno Capital Management first reported a position in Arcus Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Quantinno Capital Management's Arcus Biosciences position peaked at $380K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.